MGRX (Mangoceuticals, Inc., NASDAQ) up 50.75% intraday 20 Feb 2026: TRT sales drive heavy volume

MGRX stock jumped after Mangoceuticals, Inc. reported strong initial results from its $99 injectable TRT program, trading at USD 0.5427 intraday on the NASDAQ on 20 Feb 2026. Volume spiked to 298,139,498 shares as investors reacted to a company statement showing 336.00% month-over-month sales growth and a 54.00% drop in customer acquisition cost. The move follows heavy premarket coverage and highlights how product launches can trigger sudden intraday activity in low-float healthcare names.